Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress
22 mai 2020 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
First abstract highlights pre-clinical data linking lenabasum’s mechanism of action to inhibiting inflammasome activationSecond abstract outlines baseline characteristics of RESOLVE-1 patients in EU ...